BAFL 46.25 Increased By ▲ 0.50 (1.09%)
BIPL 20.19 Decreased By ▼ -0.03 (-0.15%)
BOP 5.30 Decreased By ▼ -0.05 (-0.93%)
CNERGY 4.61 Increased By ▲ 0.06 (1.32%)
DFML 16.61 Increased By ▲ 0.64 (4.01%)
DGKC 78.06 Decreased By ▼ -0.63 (-0.8%)
FABL 28.21 Increased By ▲ 0.36 (1.29%)
FCCL 20.07 Increased By ▲ 1.21 (6.42%)
FFL 9.14 Increased By ▲ 0.16 (1.78%)
GGL 12.84 Decreased By ▼ -0.02 (-0.16%)
HBL 111.51 Decreased By ▼ -0.39 (-0.35%)
HUBC 123.69 Increased By ▲ 1.49 (1.22%)
HUMNL 7.65 No Change ▼ 0.00 (0%)
KEL 3.27 Increased By ▲ 0.03 (0.93%)
LOTCHEM 28.30 Increased By ▲ 0.32 (1.14%)
MLCF 41.81 Decreased By ▼ -0.64 (-1.51%)
OGDC 115.39 Increased By ▲ 4.71 (4.26%)
PAEL 19.05 Increased By ▲ 0.16 (0.85%)
PIBTL 5.53 Increased By ▲ 0.06 (1.1%)
PIOC 112.85 Decreased By ▼ -2.45 (-2.12%)
PPL 100.04 Increased By ▲ 5.05 (5.32%)
PRL 25.64 Increased By ▲ 0.27 (1.06%)
SILK 1.10 Decreased By ▼ -0.01 (-0.9%)
SNGP 67.52 Increased By ▲ 3.02 (4.68%)
SSGC 12.54 Increased By ▲ 0.27 (2.2%)
TELE 8.46 Increased By ▲ 0.07 (0.83%)
TPLP 13.39 No Change ▼ 0.00 (0%)
TRG 85.46 Increased By ▲ 1.36 (1.62%)
UNITY 26.60 Increased By ▲ 0.75 (2.9%)
WTL 1.57 Increased By ▲ 0.03 (1.95%)
BR100 6,377 Increased By 82.2 (1.31%)
BR30 22,376 Increased By 439.3 (2%)
KSE100 62,493 Increased By 801.8 (1.3%)
KSE30 20,829 Increased By 274.3 (1.33%)

drugmaker

AstraZeneca commits to 1.8mn Thai vaccine doses amid supply anxiety
Business & Finance

AstraZeneca commits to 1.8mn Thai vaccine doses amid supply anxiety

  • The joint announcement by AstraZeneca and Siam Bioscience, a firm owned by Thailand's king, comes amid public anxiety about vaccine supplies, as the country suffers its most severe outbreak so far.
  • It did not say whether the Thai plant would make all 6 million doses that Thailand's government has promised would be available this month.
Published 02 Jun, 2021 06:55pm
Abbott cuts 2021 profit forecast on lower COVID-19 testing demand
Business & Finance

Abbott cuts 2021 profit forecast on lower COVID-19 testing demand

  • "This has been driven by several factors, including significant reductions in cases in the US and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, US health authority guidance on testing for fully vaccinated individuals," the drugmaker said.
  • Abbott sees second-quarter adjusted profit from continuing operations of at least $1 per share, compared with analysts' estimates of $1.23 per share.
Published 01 Jun, 2021 06:51pm
Canada approves J&J's one-dose COVID-19 vaccine
Business & Finance

Canada approves J&J's one-dose COVID-19 vaccine

  • The official announcement will be made later on Friday, said the source, who requested anonymity given the sensitivity of the situation.
  • If the J&J vaccine has been approved, it could ease some logistical challenges. The vaccine is administered in a single dose and can be stored in normal fridges while the Pfizer-BioNTech and Moderna shots must be kept in freezers.
Published 05 Mar, 2021 08:28pm
Takeda buys epilepsy treatment rights from Ovid for up to $856mn
Business & Finance

Takeda buys epilepsy treatment rights from Ovid for up to $856mn

  • Takeda will be responsible for future development and commercialization of the drug, soticlestat, worldwide and Ovid will no longer have any financial obligation, the companies said.
  • The companies in August reported results from a mid-stage study showing soticlestat met the main goal of reduction in seizure frequency.
Published 03 Mar, 2021 07:01pm
Merck to help make Johnson & Johnson's COVID-19 vaccine
Business & Finance

Merck to help make Johnson & Johnson's COVID-19 vaccine

  • After scrapping development of its own COVID-19 vaccine candidates in January, Merck last month said it was working on a deal to open up its manufacturing capacity to other vaccine makers.
  • J&J is shipping about four million doses of its vaccine in the United States this week, but the next shipments hinge on when its new, larger manufacturing plant receives regulatory approvals.
Published 02 Mar, 2021 08:34pm